Amgen
AMGN
$245.17
Share price
-0.55%
Change (1 day)
9.68%
Change (1 year)
Categories
The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
Market capitalization of Amgen (AMGN)
Market cap: $130.92 Billion
As of February 2023 Amgen has a market cap of $130.92 Billion. This makes Amgen the world's 95th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Amgen from 2001 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $130.92 B | -6.58% |
| 2022 | $140.13 B | 10.59% |
| 2021 | $126.71 B | -5.33% |
| 2020 | $133.85 B | -6.11% |
| 2019 | $142.56 B | 16.32% |
| 2018 | $122.56 B | -2.91% |
| 2017 | $126.23 B | 16.06% |
| 2016 | $108.76 B | -11.13% |
| 2015 | $122.39 B | 1.05% |
| 2014 | $121.12 B | 40.7% |
| 2013 | $86.08 B | 32.05% |
| 2012 | $65.19 B | 15.83% |
| 2011 | $56.28 B | 10% |
| 2010 | $51.16 B | -9.1% |
| 2009 | $56.28 B | -6.91% |
| 2008 | $60.46 B | 19.78% |
| 2007 | $50.48 B | -36.62% |
| 2006 | $79.64 B | -17.48% |
| 2005 | $96.52 B | 19.42% |
| 2004 | $80.82 B | 1.9% |
| 2003 | $79.31 B | 27.29% |
| 2002 | $62.31 B | 5.57% |
| 2001 | $59.02 B |
End of Day market cap according to different sources
On Feb 5th, 2023 the market cap of Amgen was reported to be:
$130.92 Billion
$130.92 Billion
$130.92 Billion
$130.81 Billion
$130.92 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $430.36 B | 228.73% | 🇺🇸 USA |
 Pfizer PFE | $247.32 B | 88.91% | 🇺🇸 USA |
 AbbVie ABBV | $256.78 B | 96.14% | 🇺🇸 USA |
 Eli Lilly LLY | $322.18 B | 146.09% | 🇺🇸 USA |
 Biogen BIIB | $40.84 B | -68.80% | 🇺🇸 USA |
 Gilead Sciences GILD | $105.98 B | -19.05% | 🇺🇸 USA |
 Illumina ILMN | $33.70 B | -74.26% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $158.29 B | 20.91% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $71.30 B | -45.54% | 🇬🇧 UK |